123 related articles for article (PubMed ID: 15799974)
1. Domain interactions of the mannose 6-phosphate/insulin-like growth factor II receptor.
Kreiling JL; Byrd JC; MacDonald RG
J Biol Chem; 2005 Jun; 280(22):21067-77. PubMed ID: 15799974
[TBL] [Abstract][Full Text] [Related]
2. An insulin-like growth factor II (IGF-II) affinity-enhancing domain localized within extracytoplasmic repeat 13 of the IGF-II/mannose 6-phosphate receptor.
Devi GR; Byrd JC; Slentz DH; MacDonald RG
Mol Endocrinol; 1998 Nov; 12(11):1661-72. PubMed ID: 9817593
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms for high affinity mannose 6-phosphate ligand binding to the insulin-like growth factor II/mannose 6-phosphate receptor.
Byrd JC; MacDonald RG
J Biol Chem; 2000 Jun; 275(25):18638-46. PubMed ID: 10764735
[TBL] [Abstract][Full Text] [Related]
4. Dimerization of the insulin-like growth factor II/mannose 6-phosphate receptor.
Byrd JC; Park JH; Schaffer BS; Garmroudi F; MacDonald RG
J Biol Chem; 2000 Jun; 275(25):18647-56. PubMed ID: 10764761
[TBL] [Abstract][Full Text] [Related]
5. Dominant-negative effect of truncated mannose 6-phosphate/insulin-like growth factor II receptor species in cancer.
Kreiling JL; Montgomery MA; Wheeler JR; Kopanic JL; Connelly CM; Zavorka ME; Allison JL; Macdonald RG
FEBS J; 2012 Aug; 279(15):2695-713. PubMed ID: 22681933
[TBL] [Abstract][Full Text] [Related]
6. Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers.
Devi GR; De Souza AT; Byrd JC; Jirtle RL; MacDonald RG
Cancer Res; 1999 Sep; 59(17):4314-9. PubMed ID: 10485478
[TBL] [Abstract][Full Text] [Related]
7. Binding of urokinase-type plasminogen activator receptor (uPAR) to the mannose 6-phosphate/insulin-like growth factor II receptor: contrasting interactions of full-length and soluble forms of uPAR.
Kreiling JL; Byrd JC; Deisz RJ; Mizukami IF; Todd RF; MacDonald RG
J Biol Chem; 2003 Jun; 278(23):20628-37. PubMed ID: 12665524
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of insulin-like growth factor II (IGF-II)-dependent cell growth by multidentate pentamannosyl 6-phosphate-based ligands targeting the mannose 6-phosphate/IGF-II receptor.
Zavorka ME; Connelly CM; Grosely R; MacDonald RG
Oncotarget; 2016 Sep; 7(38):62386-62410. PubMed ID: 27694692
[TBL] [Abstract][Full Text] [Related]
9. High-affinity ligand binding by wild-type/mutant heteromeric complexes of the mannose 6-phosphate/insulin-like growth factor II receptor.
Hartman MA; Kreiling JL; Byrd JC; MacDonald RG
FEBS J; 2009 Apr; 276(7):1915-29. PubMed ID: 19236480
[TBL] [Abstract][Full Text] [Related]
10. The bovine mannose 6-phosphate/insulin-like growth factor II receptor. The role of arginine residues in mannose 6-phosphate binding.
Dahms NM; Rose PA; Molkentin JD; Zhang Y; Brzycki MA
J Biol Chem; 1993 Mar; 268(8):5457-63. PubMed ID: 8449908
[TBL] [Abstract][Full Text] [Related]
11. Structure and function of the human Gly1619Arg polymorphism of M6P/IGF2R domain 11 implicated in IGF2 dependent growth.
Rezgui D; Williams C; Savage SA; Prince SN; Zaccheo OJ; Jones EY; Crump MP; Hassan AB
J Mol Endocrinol; 2009 Apr; 42(4):341-56. PubMed ID: 19208780
[TBL] [Abstract][Full Text] [Related]
12. Disruption of ligand binding to the insulin-like growth factor II/mannose 6-phosphate receptor by cancer-associated missense mutations.
Byrd JC; Devi GR; de Souza AT; Jirtle RL; MacDonald RG
J Biol Chem; 1999 Aug; 274(34):24408-16. PubMed ID: 10446221
[TBL] [Abstract][Full Text] [Related]
13. Localization of the carbohydrate recognition sites of the insulin-like growth factor II/mannose 6-phosphate receptor to domains 3 and 9 of the extracytoplasmic region.
Hancock MK; Yammani RD; Dahms NM
J Biol Chem; 2002 Dec; 277(49):47205-12. PubMed ID: 12374794
[TBL] [Abstract][Full Text] [Related]
14. The bovine mannose 6-phosphate/insulin-like growth factor II receptor. Localization of the insulin-like growth factor II binding site to domains 5-11.
Dahms NM; Wick DA; Brzycki-Wessell MA
J Biol Chem; 1994 Feb; 269(5):3802-9. PubMed ID: 8106425
[TBL] [Abstract][Full Text] [Related]
15. Mono- and bivalent ligands bearing mannose 6-phosphate (M6P) surrogates: targeting the M6P/insulin-like growth factor II receptor.
Berkowitz DB; Maiti G; Charette BD; Dreis CD; MacDonald RG
Org Lett; 2004 Dec; 6(26):4921-4. PubMed ID: 15606100
[TBL] [Abstract][Full Text] [Related]
16. Structure of the Human Cation-Independent Mannose 6-Phosphate/IGF2 Receptor Domains 7-11 Uncovers the Mannose 6-Phosphate Binding Site of Domain 9.
Bochel AJ; Williams C; McCoy AJ; Hoppe HJ; Winter AJ; Nicholls RD; Harlos K; Jones EY; Berger I; Hassan AB; Crump MP
Structure; 2020 Dec; 28(12):1300-1312.e5. PubMed ID: 32877646
[TBL] [Abstract][Full Text] [Related]
17. The mannose 6-phosphate-binding sites of M6P/IGF2R determine its capacity to suppress matrix invasion by squamous cell carcinoma cells.
Probst OC; Karayel E; Schida N; Nimmerfall E; Hehenberger E; Puxbaum V; Mach L
Biochem J; 2013 Apr; 451(1):91-9. PubMed ID: 23347038
[TBL] [Abstract][Full Text] [Related]
18. Identification of a low affinity mannose 6-phosphate-binding site in domain 5 of the cation-independent mannose 6-phosphate receptor.
Reddy ST; Chai W; Childs RA; Page JD; Feizi T; Dahms NM
J Biol Chem; 2004 Sep; 279(37):38658-67. PubMed ID: 15252023
[TBL] [Abstract][Full Text] [Related]
19. The rate of internalization of the mannose 6-phosphate/insulin-like growth factor II receptor is enhanced by multivalent ligand binding.
York SJ; Arneson LS; Gregory WT; Dahms NM; Kornfeld S
J Biol Chem; 1999 Jan; 274(2):1164-71. PubMed ID: 9873065
[TBL] [Abstract][Full Text] [Related]
20. Domain 5 of the cation-independent mannose 6-phosphate receptor preferentially binds phosphodiesters (mannose 6-phosphate N-acetylglucosamine ester).
Chavez CA; Bohnsack RN; Kudo M; Gotschall RR; Canfield WM; Dahms NM
Biochemistry; 2007 Nov; 46(44):12604-17. PubMed ID: 17927214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
